1. Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells
   Masanobu Tsubaki et al, 2022, Clinical and Experimental Medicine CrossRef
2. Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment
   Lingxi Jiang et al, 2023, Asian Journal of Pharmaceutical Sciences CrossRef